IBDEI0QP ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12032,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12032,1,2,0)
 ;;=2^P9010
 ;;^UTILITY(U,$J,358.3,12032,1,3,0)
 ;;=3^WHOLE BLOOD FOR TRANSFUSION,EA UNIT
 ;;^UTILITY(U,$J,358.3,12033,0)
 ;;=P9016^^48^593^4^^^^1
 ;;^UTILITY(U,$J,358.3,12033,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12033,1,2,0)
 ;;=2^P9016
 ;;^UTILITY(U,$J,358.3,12033,1,3,0)
 ;;=3^RBC LEUKOCYTES REDUCED,EA UNIT
 ;;^UTILITY(U,$J,358.3,12034,0)
 ;;=P9021^^48^593^6^^^^1
 ;;^UTILITY(U,$J,358.3,12034,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12034,1,2,0)
 ;;=2^P9021
 ;;^UTILITY(U,$J,358.3,12034,1,3,0)
 ;;=3^RED BLOOD CELLS,EA UNIT
 ;;^UTILITY(U,$J,358.3,12035,0)
 ;;=P9022^^48^593^7^^^^1
 ;;^UTILITY(U,$J,358.3,12035,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12035,1,2,0)
 ;;=2^P9022
 ;;^UTILITY(U,$J,358.3,12035,1,3,0)
 ;;=3^WASHED RED BLOOD CELLS,EA UNIT
 ;;^UTILITY(U,$J,358.3,12036,0)
 ;;=P9038^^48^593^3^^^^1
 ;;^UTILITY(U,$J,358.3,12036,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12036,1,2,0)
 ;;=2^P9038
 ;;^UTILITY(U,$J,358.3,12036,1,3,0)
 ;;=3^RBC IRRADIATED,EA UNIT
 ;;^UTILITY(U,$J,358.3,12037,0)
 ;;=P9039^^48^593^2^^^^1
 ;;^UTILITY(U,$J,358.3,12037,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12037,1,2,0)
 ;;=2^P9039
 ;;^UTILITY(U,$J,358.3,12037,1,3,0)
 ;;=3^RBC DEGLYCEROLIZED,EA UNIT
 ;;^UTILITY(U,$J,358.3,12038,0)
 ;;=P9040^^48^593^5^^^^1
 ;;^UTILITY(U,$J,358.3,12038,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12038,1,2,0)
 ;;=2^P9040
 ;;^UTILITY(U,$J,358.3,12038,1,3,0)
 ;;=3^RBC LEUKOREDUCED IRRADIATED,EA UNIT
 ;;^UTILITY(U,$J,358.3,12039,0)
 ;;=P9051^^48^593^9^^^^1
 ;;^UTILITY(U,$J,358.3,12039,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12039,1,2,0)
 ;;=2^P9051
 ;;^UTILITY(U,$J,358.3,12039,1,3,0)
 ;;=3^WHOLE BLOOD/RBC,L/R CMV-NEG,EA UNIT
 ;;^UTILITY(U,$J,358.3,12040,0)
 ;;=S9445^^48^594^5^^^^1
 ;;^UTILITY(U,$J,358.3,12040,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12040,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,12040,1,3,0)
 ;;=3^PT EDUCATION,INDIV,PER ENCOUNTER
 ;;^UTILITY(U,$J,358.3,12041,0)
 ;;=98960^^48^594^6^^^^1
 ;;^UTILITY(U,$J,358.3,12041,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12041,1,2,0)
 ;;=2^98960
 ;;^UTILITY(U,$J,358.3,12041,1,3,0)
 ;;=3^SELF-MGMT EDUC & TRAIN 1 PT,EA 30 MIN
 ;;^UTILITY(U,$J,358.3,12042,0)
 ;;=98961^^48^594^7^^^^1
 ;;^UTILITY(U,$J,358.3,12042,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12042,1,2,0)
 ;;=2^98961
 ;;^UTILITY(U,$J,358.3,12042,1,3,0)
 ;;=3^SELF-MGMT EDUC & TRAIN 2-4 PT
 ;;^UTILITY(U,$J,358.3,12043,0)
 ;;=98962^^48^594^8^^^^1
 ;;^UTILITY(U,$J,358.3,12043,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12043,1,2,0)
 ;;=2^98962
 ;;^UTILITY(U,$J,358.3,12043,1,3,0)
 ;;=3^SELF-MGMT EDUC & TRAIN 5-8 PT
 ;;^UTILITY(U,$J,358.3,12044,0)
 ;;=S9460^^48^594^4^^^^1
 ;;^UTILITY(U,$J,358.3,12044,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12044,1,2,0)
 ;;=2^S9460
 ;;^UTILITY(U,$J,358.3,12044,1,3,0)
 ;;=3^DIABETIC MGMT PROGRAM,NURSE VISIT
 ;;^UTILITY(U,$J,358.3,12045,0)
 ;;=G0108^^48^594^3^^^^1
 ;;^UTILITY(U,$J,358.3,12045,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12045,1,2,0)
 ;;=2^G0108
 ;;^UTILITY(U,$J,358.3,12045,1,3,0)
 ;;=3^DIAB OUTPT SELF-MGMT TRNG-IND,PER 30 MIN
 ;;^UTILITY(U,$J,358.3,12046,0)
 ;;=G0109^^48^594^2^^^^1
 ;;^UTILITY(U,$J,358.3,12046,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12046,1,2,0)
 ;;=2^G0109
 ;;^UTILITY(U,$J,358.3,12046,1,3,0)
 ;;=3^DIAB OUTPT SELF-MGMT TRNG-GRP,PER 30 MIN
